Blood test could revolutionize throat cancer monitoring
NCT ID NCT05539638
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a blood test that looks for tiny pieces of cancer DNA in the bloodstream of people with throat cancer. The goal is to see if this test can track how well treatment is working and spot if the cancer comes back earlier than current methods. Researchers will collect blood samples from 250 participants over time and compare the results with standard scans and biopsies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMAVIRUS (HPV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Glasgow Royal Infirmary
RECRUITINGGlasgow, United Kingdom
-
Monklands Hospital ENT
RECRUITINGAirdrie, United Kingdom
-
Ninewells Hospital
NOT_YET_RECRUITINGDundee, DD2 1SG, DD2 1SG, United Kingdom
-
Summerfield House - NHS Grampian
NOT_YET_RECRUITINGAberdeen, AB15 6RE, United Kingdom
-
The Royal Infirmiry
NOT_YET_RECRUITINGEdinburgh, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can less radiation be safer for throat cancer?
- Can a vaccine plus a Blood-Vessel blocker stop airway growths from coming back?
- Can a simple swab predict who needs less radiation?
- New drug combo aims to shrink oral cancers before surgery
- Acupuncture timing may be key to preventing dry mouth in head and neck cancer patients
- New Vaccine-Drug combo aims to tame HPV throat cancer with less radiation